Eivor Elovaara

3.2k citations
84 papers · 2.7k indexed · h-index 32
Topics
Pharmacogenetics and Drug Metabolism (47 papers)Carcinogens and Genotoxicity Assessment (34 papers)Analytical Chemistry and Chromatography (11 papers)
Journals
SHILAP Revista de lepidopterologíaAnalytical ChemistryEnvironmental Health Perspectives
Partner nations
FinlandFranceJapan

In The Last Decade

Eivor Elovaara

82 papers receiving 2.5k citations

Peers

Eivor Elovaara
Comparison fields: 5 of 122
  • Cancer Research 969
  • Molecular Biology 834
  • Pharmacology 788
  • Health, Toxicology and Mutagenesis 723
  • Plant Science 412
Replace H.B. Matthews with:
H.B. Matthews United States
Robert Snyder United States
Douglas E. Rickert United States
Leo T. Burka United States
H. Kappus Germany
Masakuni Degawa Japan
Jeffrey R. Fry United Kingdom
James J. Kocsis United States
Alan R. Dahl United States
Clifford R. Elcombe United Kingdom
Eivor Elovaara relative to H.B. Matthews United States H.B. Matthews's profile →
Citations per field
00.5×1.5×
H.B. Matthews · 1×
Citations per year

Countries citing papers authored by Eivor Elovaara

Since Specialization
Citations

This map shows the geographic impact of Eivor Elovaara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eivor Elovaara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eivor Elovaara more than expected).

Fields of papers citing papers by Eivor Elovaara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eivor Elovaara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eivor Elovaara. The network helps show where Eivor Elovaara may publish in the future.

Co-authorship network of co-authors of Eivor Elovaara

This figure shows the co-authorship network connecting the top 25 collaborators of Eivor Elovaara. A scholar is included among the top collaborators of Eivor Elovaara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eivor Elovaara. Eivor Elovaara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 49
2 14
3 54
4 43
5 63
6 15
7 31
8 77
9 45
10 152
11 10
12 37
13 151
14 105
15 2
16 17
17 18
18 20
19 41
20 28

About Eivor Elovaara

Eivor Elovaara is a scholar working on Pharmacology, Chemical Health and Safety and Biochemistry, having authored 84 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (47 papers), Carcinogens and Genotoxicity Assessment (34 papers) and Analytical Chemistry and Chromatography (11 papers). The work is most often cited by research in Pharmacology (788 citations), Cancer Research (969 citations) and Health, Toxicology and Mutagenesis (723 citations). Eivor Elovaara has collaborated with scholars based in Finland, France and Japan. Frequent co-authors include Harri Vainio, Jouni Mikkola, Tamie Nakajima, Harry V. Gelboin, H. Savolainen, Tamie Nakajima, Jyrki Taskinen, Ari Hirvonen, Hannu Raunio and Leena Luukkanen. Their work appears in journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Environmental Health Perspectives.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026